ASTH Financial Statements

Balance sheet, income statement, cash flow, and dividends for Apollo Medical Holdings Inc (ASTH).


$1.77B Market Cap.

As of 03/14/2025 5:00 PM ET (MRY) • Disclaimer

ASTH Market Cap. (MRY)


ASTH Shares Outstanding (MRY)


ASTH Assets (MRY)


Total Assets

$1.35B

Total Liabilities

$840.73M

Total Investments

$102.50M

ASTH Income (MRY)


Revenue

$2.03B

Net Income

$43.15M

Operating Expense

$182.04M

ASTH Cash Flow (MRY)


CF Operations

$52.20M

CF Investing

-$192.40M

CF Financing

$135.15M

ASTH Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ASTH Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$1,354,894,000 (45.16%)

$933,361,000 (-3.40%)

$966,213,000 (11.40%)

$867,361,000 (6.10%)

Assets Current

$638,496,000 (38.35%)

$461,507,000 (7.80%)

$428,125,000 (5.85%)

$404,460,000 (19.46%)

Assets Non-Current

$716,398,000 (51.83%)

$471,854,000 (-12.31%)

$538,088,000 (16.24%)

$462,901,000 (-3.34%)

Goodwill & Intangible Assets

$537,432,000 (53.34%)

$350,479,000 (1.32%)

$345,914,000 (5.07%)

$329,223,000 (0.98%)

Shareholders Equity

$712,720,000 (16.04%)

$614,218,000 (13.21%)

$542,561,000 (21.06%)

$448,167,000 (35.47%)

Property Plant & Equipment Net

$46,875,000 (5.18%)

$44,567,000 (-65.45%)

$128,980,000 (87.94%)

$68,627,000 (41.60%)

Cash & Equivalents

$288,455,000 (-1.82%)

$293,807,000 (2.01%)

$288,027,000 (23.57%)

$233,097,000 (20.48%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$102,505,000 (66.71%)

$61,486,000 (23.26%)

$49,883,000 (-50.41%)

$100,597,000 (-34.33%)

Investments Current

$2,378,000 (-4.80%)

$2,498,000 (-71.25%)

$8,688,000 (-84.87%)

$57,417,000 (-15.18%)

Investments Non-Current

$100,127,000 (69.74%)

$58,988,000 (43.19%)

$41,195,000 (-4.60%)

$43,180,000 (-49.49%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$305,486,000 (122.83%)

$137,095,000 (17.57%)

$116,612,000 (30.10%)

$89,631,000 (47.87%)

Trade & Non-Trade Payables

$114,365,000 (68.96%)

$67,686,000 (17.46%)

$57,627,000 (5.77%)

$54,485,000 (19.00%)

Accumulated Retained Earnings (Deficit)

$286,283,000 (17.75%)

$243,134,000 (33.28%)

$182,417,000 (32.91%)

$137,246,000 (96.71%)

Tax Assets

$35,259,000 (32.55%)

$26,600,000 (66.84%)

$15,943,000 (-26.26%)

$21,621,000 (0%)

Tax Liabilities

$4,555,000 (11.86%)

$4,072,000 (-77.98%)

$18,496,000 (-38.62%)

$30,135,000 (98.48%)

Total Debt

$471,839,000 (46.98%)

$321,014,000 (39.96%)

$229,364,000 (14.12%)

$200,983,000 (-22.86%)

Debt Current

$15,279,000 (-38.27%)

$24,753,000 (417.30%)

$4,785,000 (22.85%)

$3,895,000 (-72.51%)

Debt Non-Current

$456,560,000 (54.11%)

$296,261,000 (31.92%)

$224,579,000 (13.95%)

$197,088,000 (-20.01%)

Total Liabilities

$840,726,000 (60.88%)

$522,593,000 (28.19%)

$407,666,000 (14.28%)

$356,719,000 (-4.19%)

Liabilities Current

$365,608,000 (67.19%)

$218,674,000 (47.15%)

$148,610,000 (29.54%)

$114,719,000 (-0.24%)

Liabilities Non-Current

$475,118,000 (56.33%)

$303,919,000 (17.32%)

$259,056,000 (7.05%)

$242,000,000 (-5.96%)

ASTH Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$2,034,540,000 (46.72%)

$1,386,661,000 (21.19%)

$1,144,163,000 (47.84%)

$773,915,000 (12.62%)

Cost of Revenue

$1,763,152,000 (50.48%)

$1,171,703,000 (24.03%)

$944,685,000 (58.47%)

$596,142,000 (10.56%)

Selling General & Administrative Expense

$154,111,000 (36.87%)

$112,597,000 (44.97%)

$77,670,000 (25.12%)

$62,077,000 (26.39%)

Research & Development Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Expenses

$182,038,000 (39.66%)

$130,345,000 (36.90%)

$95,213,000 (19.62%)

$79,594,000 (17.98%)

Interest Expense

$33,097,000 (105.55%)

$16,102,000 (103.31%)

$7,920,000 (46.83%)

$5,394,000 (-43.22%)

Income Tax Expense

$30,886,000 (-3.45%)

$31,989,000 (-21.74%)

$40,875,000 (28.97%)

$31,693,000 (-43.75%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$49,932,000 (-13.69%)

$57,849,000 (26.47%)

$45,741,000 (-0.68%)

$46,055,000 (-62.28%)

Net Income to Non-Controlling Interests

$6,783,000 (336.51%)

-$2,868,000 (-603.16%)

$570,000 (102.49%)

-$22,868,000 (-127.10%)

Net Income

$43,149,000 (-28.93%)

$60,717,000 (34.42%)

$45,171,000 (-34.46%)

$68,923,000 (82.88%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$43,149,000 (-28.93%)

$60,717,000 (34.42%)

$45,171,000 (-34.46%)

$68,923,000 (82.88%)

Weighted Average Shares

$56,252,730 (-3.48%)

$58,283,589 (2.75%)

$56,723,447 (2.11%)

$55,549,053 (52.07%)

Weighted Average Shares Diluted

-

-

-

-

Earning Before Interest & Taxes (EBIT)

$107,132,000 (-1.54%)

$108,808,000 (15.80%)

$93,966,000 (-11.36%)

$106,010,000 (2.39%)

Gross Profit

$271,388,000 (26.25%)

$214,958,000 (7.76%)

$199,478,000 (12.21%)

$177,773,000 (20.14%)

Operating Income

$89,350,000 (5.60%)

$84,613,000 (-18.85%)

$104,265,000 (6.20%)

$98,179,000 (21.96%)

ASTH Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$192,395,000 (-193.63%)

-$65,523,000 (-821.17%)

-$7,113,000 (-143.00%)

$16,540,000 (-82.68%)

Net Cash Flow from Financing

$135,146,000 (3850.48%)

$3,421,000 (117.03%)

-$20,085,000 (57.94%)

-$47,748,000 (7.64%)

Net Cash Flow from Operations

$52,198,000 (-23.49%)

$68,227,000 (-16.93%)

$82,128,000 (16.77%)

$70,335,000 (52.36%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$5,051,000 (-182.47%)

$6,125,000 (-88.85%)

$54,930,000 (40.39%)

$39,127,000 (-56.51%)

Net Cash Flow - Business Acquisitions and Disposals

-$146,004,000 (-3706.15%)

-$3,836,000 (68.77%)

-$12,285,000 (-461.54%)

$3,398,000 (-33.97%)

Net Cash Flow - Investment Acquisitions and Disposals

-$38,360,000 (-15.69%)

-$33,158,000 (-217.95%)

$28,112,000 (-13.14%)

$32,365,000 (-64.61%)

Capital Expenditure

-$8,031,000 (71.85%)

-$28,529,000 (-24.36%)

-$22,940,000 (-19.34%)

-$19,223,000 (-1625.58%)

Issuance (Repayment) of Debt Securities

$144,163,000 (91.60%)

$75,243,000 (9187.32%)

-$828,000 (98.57%)

-$57,965,000 (-503.49%)

Issuance (Purchase) of Equity Shares

$89,000 (101.03%)

-$8,670,000 (-1305.19%)

-$617,000 (-101.42%)

$43,456,000 (323.34%)

Payment of Dividends & Other Cash Distributions

-$4,036,000 (93.50%)

-$62,074,000 (-342.44%)

-$14,030,000 (54.87%)

-$31,089,000 (39.42%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$34,536,000 (56.70%)

$22,040,000 (36.89%)

$16,101,000 (138.71%)

$6,745,000 (99.38%)

Depreciation Amortization & Accretion

$33,205,000 (33.19%)

$24,931,000 (42.11%)

$17,543,000 (0.15%)

$17,517,000 (-4.54%)

ASTH Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

13.30% (-14.19%)

15.50% (-10.92%)

17.40% (-24.35%)

23.00% (6.98%)

Profit Margin

2.10% (-52.27%)

4.40% (12.82%)

3.90% (-56.18%)

8.90% (61.82%)

EBITDA Margin

6.90% (-28.12%)

9.60% (-1.03%)

9.70% (-39.38%)

16.00% (-9.60%)

Return on Average Equity (ROAE)

6.30% (-40.00%)

10.50% (16.67%)

9.00% (-46.75%)

16.90% (8.33%)

Return on Average Assets (ROAA)

3.40% (-43.33%)

6.00% (25.00%)

4.80% (-39.24%)

7.90% (68.09%)

Return on Sales (ROS)

5.30% (-32.05%)

7.80% (-4.88%)

8.20% (-40.15%)

13.70% (-9.27%)

Return on Invested Capital (ROIC)

19.30% (-23.11%)

25.10% (14.61%)

21.90% (-10.61%)

24.50% (6.52%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

34.65 (17.60%)

29.46 (-0.43%)

29.59 (-36.78%)

46.8 (163.86%)

Price to Sales Ratio (P/S)

0.87 (-45.84%)

1.61 (9.75%)

1.47 (-72.18%)

5.27 (443.15%)

Price to Book Ratio (P/B)

2.49 (-31.51%)

3.63 (17.45%)

3.09 (-66.03%)

9.11 (203.90%)

Debt to Equity Ratio (D/E)

1.18 (38.66%)

0.85 (13.32%)

0.75 (-5.65%)

0.8 (-29.24%)

Earnings Per Share (EPS)

0.91 (-30.00%)

1.3 (30.00%)

1 (-36.31%)

1.57 (52.43%)

Sales Per Share (SPS)

36.17 (52.02%)

23.79 (17.95%)

20.17 (44.78%)

13.93 (-25.94%)

Free Cash Flow Per Share (FCFPS)

0.79 (15.27%)

0.68 (-34.71%)

1.04 (13.37%)

0.92 (-25.39%)

Book Value Per Share (BVPS)

12.67 (20.23%)

10.54 (10.17%)

9.56 (18.55%)

8.07 (-10.92%)

Tangible Assets Book Value Per Share (TABVPS)

14.53 (45.31%)

10 (-8.54%)

10.94 (12.87%)

9.69 (-27.99%)

Enterprise Value Over EBIT (EV/EBIT)

18 (-10.00%)

20 (11.11%)

18 (-52.63%)

38 (280.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

13.55 (-17.40%)

16.4 (6.50%)

15.4 (-53.33%)

33 (272.04%)

Asset Turnover

1.59 (15.64%)

1.38 (13.36%)

1.21 (36.29%)

0.89 (3.25%)

Current Ratio

1.75 (-17.25%)

2.11 (-26.76%)

2.88 (-18.29%)

3.53 (19.77%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$44,167,000 (11.26%)

$39,698,000 (-32.93%)

$59,188,000 (15.80%)

$51,112,000 (13.46%)

Enterprise Value (EV)

$1,901,473,577 (-13.33%)

$2,193,908,459 (27.74%)

$1,717,533,797 (-57.87%)

$4,076,841,414 (277.05%)

Earnings Before Tax (EBT)

$74,035,000 (-20.14%)

$92,706,000 (7.74%)

$86,046,000 (-14.48%)

$100,616,000 (7.00%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$140,337,000 (4.93%)

$133,739,000 (19.94%)

$111,509,000 (-9.73%)

$123,527,000 (1.35%)

Invested Capital

$635,238,000 (62.29%)

$391,415,000 (-5.23%)

$413,026,000 (5.55%)

$391,305,000 (-11.78%)

Working Capital

$272,888,000 (12.38%)

$242,833,000 (-13.12%)

$279,515,000 (-3.53%)

$289,741,000 (29.59%)

Tangible Asset Value

$817,462,000 (40.24%)

$582,882,000 (-6.03%)

$620,299,000 (15.27%)

$538,138,000 (9.50%)

Market Capitalization

$1,773,648,577 (-20.54%)

$2,232,261,459 (33.00%)

$1,678,446,797 (-58.88%)

$4,081,744,414 (311.70%)

Average Equity

$687,425,000 (18.41%)

$580,559,250 (15.71%)

$501,737,500 (22.79%)

$408,628,750 (69.67%)

Average Assets

$1,279,754,500 (26.94%)

$1,008,185,000 (6.88%)

$943,253,500 (8.53%)

$869,091,250 (9.00%)

Invested Capital Average

$555,868,750 (28.13%)

$433,822,500 (1.10%)

$429,099,000 (-0.83%)

$432,691,750 (-3.86%)

Shares

56,252,730 (-3.48%)

58,283,589 (2.75%)

56,723,447 (2.11%)

55,549,053 (2.37%)